The prediction of effects and side effects of ADHD treatment drugs (atomoxetine and methylphenidate).

The prediction of effects and side effects of ADHD treatment drugs (atomoxetine and methylphenidate). - The prediction of effects and side effects of ADHD treatment drugs (atomoxetine and methylphenidate).

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035417

Enrollment

100

Registered

2018-12-31

Start date

2012-01-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit / hyperactivity disorder

Interventions

The 8 weeks administration of atimoxetine (start with dose of 0.5-0.8mg/kg, and increase to 1.0-1.2, 1.5-1.8mg/kg every 2 weeks. In the case with adverse effect or sufficient effect, continue the same

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ADHD

Exclusion criteria

Exclusion criteria: other drugs

Design outcomes

Primary

Measure	Time frame
Prefrontal cortical activity by NIRS measurement and ADHD-RS(children), CAARS(adults) at baseline and 8 weeks after drug administration.	—

Secondary

Measure	Time frame
Polymorphisms of CYP2D6, DAT and NET	—

Countries

Japan

Contacts

Public ContactAtsunori SUGIMOTO

Niigata University Graduate School of Medical and Dental Sciences Department of Community Psychiatric Medicine

sugimoto-pedpsy@umin.ac.jp+81-25-227-2213

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026